Phosphine

Phosphine

SCHEMBL2593813

O=S(=O)(O)c1ccccc1-c1cccc([Au])c1-c1ccccc1S(=O)(=O)O.P

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGAM1 P18669 1/20 0.41
NFKB1 P19838 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
KDM4A O75164 1/20 0.36
USP2 O75604 1/20 0.36
NSD2 O96028 1/20 0.36
ALPL P05186 1/20 0.36
PLCG1 P19174 1/20 0.36
TNNI3 P19429 1/20 0.36
TNNT2 P45379 1/20 0.36
MMP14 P50281 1/20 0.36
CASP6 P55212 1/20 0.36
TNNC1 P63316 1/20 0.36
KDM4C Q9H3R0 1/20 0.36
TTR P02766 2/20 0.36
ALDH1A1 P00352 4/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MAPT P10636 3/20 0.35
LMNA P02545 2/20 0.35
GNG2 P59768 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL458284 0.79 SMN1; SMN2 (0.48) PGAM1NFKB1L3MBTL1KDM4AUSP2
SCHEMBL2592300 0.79 PGAM1 (0.44) PGAM1NFKB1L3MBTL1KDM4AUSP2
SCHEMBL8145542 0.77 PGAM1 (0.42) PGAM1NFKB1L3MBTL1KDM4AUSP2
SCHEMBL28837581 0.77 SMN1; SMN2 (0.46) PGAM1NFKB1L3MBTL1KDM4AUSP2
Water SCHEMBL3801022 0.76 PGAM1 (0.41) PGAM1NFKB1L3MBTL1KDM4AUSP2
SCHEMBL24631331 0.75 TTR (0.47) PGAM1TTRALDH1A1SMN1; SMN2MAPT
SCHEMBL9763220 0.74 MAPT (0.52) PGAM1NFKB1L3MBTL1KDM4AUSP2
SCHEMBL4875071 0.74 PGAM1 (0.44) PGAM1PLCG1TTRALDH1A1SMN1; SMN2
SCHEMBL29945057 0.74 PGAM1 (0.44) PGAM1PLCG1TTRALDH1A1SMN1; SMN2
SCHEMBL460174 0.73 STAT3 (0.51) PGAM1NFKB1L3MBTL1KDM4AUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11740233-B2 Antibody-nanoparticle conjugates and methods for making and using such conjugates VENTANA MEDICAL SYSTEMS, INC. (US) 2023-08-29 US disclosed
US-20180372733-A1 ANTIBODY-NANOPARTICLE CONJUGATES AND METHODS FOR MAKING AND USING SUCH CONJUGATES VENTANA MED SYST INC (US) 2018-12-27 US disclosed
US-10031134-B2 Antibody-nanoparticle conjugates and methods for making and using such conjugates VENTANA MEDICAL SYSTEMS, INC. (US) 2018-07-24 US disclosed
EP-2564203-B1 ANTIBODY-NANOPARTICLE CONJUGATES AND METHODS FOR MAKING AND USING SUCH CONJUGATES VENTANA MED SYST INC (US) 2017-06-07 EP disclosed
US-20170131271-A1 ANTIBODY-NANOPARTICLE CONJUGATES AND METHODS FOR MAKING AND USING SUCH CONJUGATES VENTANA MEDICAL SYSTEMS, INC. 2017-05-11 US disclosed
US-9442107-B2 Antibody-nanoparticle conjugates and methods for making and using such conjugates VENTANA MEDICAL SYSTEMS, INC. (US) 2016-09-13 US disclosed
US-20160116462-A1 ANTIBODY-NANOPARTICLE CONJUGATES AND METHODS FOR MAKING AND USING SUCH CONJUGATES VENTANA MEDICAL SYSTEMS, INC. 2016-04-28 US disclosed
US-9040310-B2 Antibody-nanoparticle conjugates and methods for making and using such conjugates VENTANA MEDICAL SYSTEMS, INC. (US) 2015-05-26 US disclosed
EP-2564203-A2 ANTIBODY-NANOPARTICLE CONJUGATES AND METHODS FOR MAKING AND USING SUCH CONJUGATES Ventana Medical Systems, Inc. (US) 2013-03-06 EP disclosed
US-20130034854-A1 Antibody-Nanoparticle Conjugates and Methods for Making and Using Such Conjugates VENTANA MEDICAL SYSTEMS, INC. (US) 2013-02-07 US disclosed
WO-2011139792-A2 ANTIBODY-NANOPARTICLE CONJUGATES AND METHODS FOR MAKING AND USING SUCH CONJUGATES VENTANA MEDICAL SYSTEMS, INC. (US) 2011-11-10 WO disclosed